Skip to main content
Year archive

Kamada Ltd. — 2022 filings

All 58 regulatory filings released by Kamada Ltd. (KMDA) in 2022, sourced directly from the official regulator.

58 Filings
2022 Period
2022 filings (58)
Filing Released Lang
Notice of Results of the 2022 Annual General Meeting of Shareholders held on December 22, 2022
Declaration of Voting Results & Voting Rights Announcements
2022-12-22 English
Notice of Results of the 2022 Annual General Meeting of Shareholders held on December 22, 2022
AGM Information
2022-12-22 English
Kamada Announces Planned Transition of Chief Financial Officer
Board/Management Information
2022-12-19 English
Kamada Announces Planned Transition of Chief Financial Officer
Report Publication Announcement
2022-12-19 English
Strong Third Quarter Financial Results Demonstrating Successful Strategic Transition and Reiterates 2022 Financial Guidance
Interim / Quarterly Report Q3 2022
2022-11-22 English
Strong Third Quarter Financial Results Demonstrating Successful Strategic Transition and Reiterates 2022 Financial Guidance
Earnings Release Q3 2022
2022-11-22 English
Annual General Meeting on Thursday, December 22, 2022, at 2:00 p.m. (Israel time)- Amended
Proxy Solicitation & Information Statement
2022-11-17 English
Annual General Meeting on Thursday, December 22, 2022, at 2:00 p.m. (Israel time)- Amended
Remuneration Information
2022-11-17 English
Annual General Meeting on Thursday, December 22, 2022, at 2:00 p.m. (Israel time)- Amended
AGM Information
2022-11-17 English
to Announce Third Quarter and First Nine Months Ended September 30, 2022 Financial Results and Host Conference Call on November 22, 2022
Report Publication Announcement
2022-11-16 English
to Announce Third Quarter and First Nine Months Ended September 30, 2022 Financial Results and Host Conference Call on November 22, 2022
Report Publication Announcement
2022-11-16 English
Annual General Meeting to be held on December 22, 2022
Proxy Solicitation & Information Statement
2022-11-08 English
Annual General Meeting to be held on December 22, 2022
Proxy Solicitation & Information Statement
2022-11-08 English
Annual General Meeting to be held on December 22, 2022
AGM Information
2022-11-08 English
FORM 6-K-Annual General Meeting on Thursday, December 22, 2022, at 2:00 p.m. (Israel time)
Proxy Solicitation & Information Statement
2022-11-08 English
FORM 6-K-Annual General Meeting on Thursday, December 22, 2022, at 2:00 p.m. (Israel time)
AGM Information
2022-11-08 English
Kamada Provides Update on Recent Progress Achieved in Ongoing Pivotal Phase 3 Clinical Trial of Inhaled AAT
Regulatory Filings
2022-11-07 English
Kamada Provides Update on Recent Progress Achieved in Ongoing Pivotal Phase 3 Clinical Trial of Inhaled AAT
Report Publication Announcement
2022-11-07 English
Kamada to Present at the Credit Suisse 31st Annual Healthcare Conference
Regulatory Filings
2022-10-26 English
Kamada to Present at the Credit Suisse 31st Annual Healthcare Conference
Report Publication Announcement
2022-10-26 English
Kamada Awarded $22 Million Extension of Canadian Supply Tender
Regulatory Filings
2022-10-19 English
Kamada Awarded $22 Million Extension of Canadian Supply Tender
Report Publication Announcement
2022-10-19 English
Second Quarter and First Half 2022 Financial Results
Interim / Quarterly Report H1 2022
2022-08-17 English
Second Quarter and First Half 2022 Financial Results
Report Publication Announcement
2022-08-17 English
Announce Second Quarter and First Half Ended June 30, 2022 Financial Results and Host Conference Call on August 17, 2022
Earnings Release H1 2022
2022-08-10 English
Announce Second Quarter and First Half Ended June 30, 2022 Financial Results and Host Conference Call on August 17, 2022
Report Publication Announcement
2022-08-10 English
Resolution the Labor Strike at the Company’s Manufacturing Facility in Israel
Regulatory Filings
2022-07-15 English
Resolution the Labor Strike at the Company’s Manufacturing Facility in Israel
Regulatory Filings
2022-07-15 English
Kamada Announces $11.4 Million International VARIZIG® Procurement Agreement
Regulatory Filings
2022-07-06 English
Kamada Announces $11.4 Million International VARIZIG® Procurement Agreement
Report Publication Announcement
2022-07-06 English
Registration Statement on Form S-8
Share Issue/Capital Change
2022-06-28 English
Registration Statement on Form S-8
Regulatory Filings
2022-06-28 English
Kamada Strengthens Senior Leadership Team; Furthering Commitment as a Fully Integrated Global Leader in the Specialty Plasma Derived Therapeutics Market
Board/Management Information
2022-06-15 English
Kamada Strengthens Senior Leadership Team; Furthering Commitment as a Fully Integrated Global Leader in the Specialty Plasma Derived Therapeutics Market
Board/Management Information
2022-06-15 English
Kamada to Host a Virtual Analysts and Investors Meeting to Review its Growth Catalysts
Regulatory Filings
2022-06-01 English
Kamada to Host a Virtual Analysts and Investors Meeting to Review its Growth Catalysts
Report Publication Announcement
2022-06-01 English
Kamada Reports First Quarter 2022 Financial Results
Interim / Quarterly Report Q1 2022
2022-05-17 English
Kamada Reports First Quarter 2022 Financial Results
Report Publication Announcement
2022-05-17 English
Kamada Announces Expansion of Pivotal Phase 3 Clinical Trial of Inhaled AAT to Additional Six Clinical Sites Across Europe; and Positive Recommendation by DSMB to Continue the Trial Without Modificati
Regulatory Filings
2022-05-17 English
Kamada Announces Expansion of Pivotal Phase 3 Clinical Trial of Inhaled AAT to Additional Six Clinical Sites Across Europe; and Positive Recommendation by DSMB to Continue the Trial Without Modificati
Regulatory Filings
2022-05-17 English
Will release First Quarter 2022 Financial Results and conference call on Tuesday, May 17, 2022.
Earnings Release Q1 2022
2022-05-11 English
Will release First Quarter 2022 Financial Results and conference call on Tuesday, May 17, 2022.
Report Publication Announcement
2022-05-11 English
Kamada Announce Receipt a Notice from the Employee's Committee of a Labor Strike in the Beit Kama plant
Regulatory Filings
2022-04-26 English
Kamada Announce Receipt a Notice from the Employee's Committee of a Labor Strike in the Beit Kama plant
Report Publication Announcement
2022-04-26 English
Kamada Issues 2022 CEO Letter to Shareholders
Management Reports
2022-03-15 English
Kamada Issues 2022 CEO Letter to Shareholders
Report Publication Announcement
2022-03-15 English
Kamada Files Annual Report for the Year Ended December 31, 2021
Report Publication Announcement
2022-03-15 English
Kamada Files Annual Report for the Year Ended December 31, 2021
Report Publication Announcement
2022-03-15 English
20F annual report 2021
Annual Report FY 2021
2022-03-15 English
20F annual report 2021
Report Publication Announcement FY 2021
2022-03-15 English
Kamada Reports Fiscal Year and Fourth Quarter 2021 Financial Results
Earnings Release Q4 2021
2022-03-15 English
Kamada Reports Fiscal Year and Fourth Quarter 2021 Financial Results
Earnings Release Q4 2021
2022-03-15 English
Kamada Expands U.S. Leadership Team with Two Key Appointments
Regulatory Filings
2022-03-14 English
Kamada Expands U.S. Leadership Team with Two Key Appointments
Report Publication Announcement
2022-03-14 English
Kamada to announce receipt of a notice of Labor Dispute from Employee’s Committee
Regulatory Filings
2022-03-03 English
Kamada to announce receipt of a notice of Labor Dispute from Employee’s Committee
Report Publication Announcement
2022-03-03 English
Kamada to Announce Fourth Quarter and Fiscal Year Ended December 31, 2021 Financial Results, and Host Conference Call on March 15, 2022
Earnings Release FY 2021
2022-03-02 English
Kamada to Announce Fourth Quarter and Fiscal Year Ended December 31, 2021 Financial Results, and Host Conference Call on March 15, 2022
Report Publication Announcement
2022-03-02 English